Literature DB >> 11275362

Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation.

M Y Jung1, H J Kang, A Moon.   

Abstract

Hepatocellular carcinoma is one of the most lethal malignancies and there is no effective preventive measure in this highly malignant disease to date. In the present study, we investigated the chemopreventive potential of capsaicin (8-methyl-N- vanillyl-6-nonenamide), the principal pungent ingredient found in hot red pepper, in SK-Hep-1 hepatocellular carcinoma cells. Treatment of capsaicin inhibited growth of SK-Hep-1 cells in a concentration-dependent manner while 4-methoxy capsaicin (Met-capsaicin) was less potent. This inhibitory effect of capsaicin on SK-Hep-1 cell growth was mainly due to the induction of apoptosis as evidenced by DNA fragmentation and nuclear condensation. Furthermore, capsaicin prominently reduced the ratio of anti-apoptotic Bcl-2 to pro-apoptotic Bax and consequently increased caspase-3 activity. These results demonstrate that capsaicin efficiently induced apoptosis in SK-Hep-1 cells through a caspase-3-dependent mechanism, which may contribute to its chemopreventive function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275362     DOI: 10.1016/s0304-3835(01)00426-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  36 in total

1.  Capsaicin may slow PSA doubling time: case report and literature review.

Authors:  Bojana Jankovic; D Andrew Loblaw; Robert Nam
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

Review 2.  New therapeutic approach for myeloid leukemia: induction of apoptosis via modulation of reactive oxygen species production by natural compounds.

Authors:  Masahiro Kizaki
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

3.  Apoptosis signal-regulating kinase 1-thioredoxin complex dissociation by capsaicin causes pancreatic tumor growth suppression by inducing apoptosis.

Authors:  Kartick C Pramanik; Sanjay K Srivastava
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

4.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling.

Authors:  Su-Shan Zhang; Yu-Hao Ni; Chen-Ru Zhao; Zhen Qiao; Hong-Xia Yu; Lu-Yao Wang; Jin-Yan Sun; Chen Du; Jia-Hao Zhang; Li-Ying Dong; KeWei Wang; Jian-Jun Gao
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

6.  TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective.

Authors:  Massimo Lazzeri; Elisabetta Costantini; Massimo Porena
Journal:  Ther Adv Urol       Date:  2009-04

7.  Chemoprevention against hepatocellular carcinoma.

Authors:  Jun-Ichi Okano; Yuki Fujise; Ryo Abe; Ryu Imamoto; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2011-06-04

Review 8.  An updated review on molecular mechanisms underlying the anticancer effects of capsaicin.

Authors:  Seok-Cheol Cho; Hyosung Lee; Bu Young Choi
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

9.  RPF151, a novel capsaicin-like analogue: in vitro studies and in vivo preclinical antitumor evaluation in a breast cancer model.

Authors:  Adilson Kleber Ferreira; Maurício Temotheo Tavares; Kerly Fernanda Mesquita Pasqualoto; Ricardo Alexandre de Azevedo; Sarah Fernandes Teixeira; Wilson Alves Ferreira-Junior; Ariane Matiello Bertin; Paulo Luiz de-Sá-Junior; José Alexandre Marzagão Barbuto; Carlos Rogério Figueiredo; Yara Cury; Mariana Celestina Frojuello Costa Bernstorff Damião; Roberto Parise-Filho
Journal:  Tumour Biol       Date:  2015-04-20

10.  Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway.

Authors:  Dong Hoon Shin; Ok Hee Kim; Hye Seung Jun; Mi Kyung Kang
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.